Commitment COM-021
Post-approval commitment for FDA-2024-0021. Category: Risk Management. Priority: high.
Commitment ID
COM-021
Application
Authority
Food and Drug Administration
Category
Risk Management
Priority
high
Status
Overdue
Due Date
2025-07-02
Completed At
—
Owner
Aisha Okonkwo
Created
2022-07-04
Description
Submit final study report for paediatric use study KCL-PED-001
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.